1. Home
  2. EBON vs GBIO Comparison

EBON vs GBIO Comparison

Compare EBON & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBON
  • GBIO
  • Stock Information
  • Founded
  • EBON 2010
  • GBIO 2016
  • Country
  • EBON China
  • GBIO United States
  • Employees
  • EBON N/A
  • GBIO N/A
  • Industry
  • EBON Semiconductors
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • EBON Technology
  • GBIO Health Care
  • Exchange
  • EBON Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • EBON 25.3M
  • GBIO 29.2M
  • IPO Year
  • EBON 2020
  • GBIO 2020
  • Fundamental
  • Price
  • EBON $5.11
  • GBIO $0.39
  • Analyst Decision
  • EBON
  • GBIO Strong Buy
  • Analyst Count
  • EBON 0
  • GBIO 4
  • Target Price
  • EBON N/A
  • GBIO $7.33
  • AVG Volume (30 Days)
  • EBON 31.3K
  • GBIO 1.1M
  • Earning Date
  • EBON 08-22-2025
  • GBIO 08-06-2025
  • Dividend Yield
  • EBON N/A
  • GBIO N/A
  • EPS Growth
  • EBON N/A
  • GBIO N/A
  • EPS
  • EBON N/A
  • GBIO N/A
  • Revenue
  • EBON $5,868,771.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • EBON N/A
  • GBIO N/A
  • Revenue Next Year
  • EBON N/A
  • GBIO N/A
  • P/E Ratio
  • EBON N/A
  • GBIO N/A
  • Revenue Growth
  • EBON 20.88
  • GBIO 146.47
  • 52 Week Low
  • EBON $3.00
  • GBIO $0.30
  • 52 Week High
  • EBON $10.94
  • GBIO $3.65
  • Technical
  • Relative Strength Index (RSI)
  • EBON 75.89
  • GBIO 52.02
  • Support Level
  • EBON $3.28
  • GBIO $0.32
  • Resistance Level
  • EBON $3.49
  • GBIO $0.36
  • Average True Range (ATR)
  • EBON 0.31
  • GBIO 0.03
  • MACD
  • EBON 0.09
  • GBIO 0.00
  • Stochastic Oscillator
  • EBON 95.54
  • GBIO 81.00

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: